{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:04:12Z","timestamp":1760043852603},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10096-016-2586-z","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T12:32:13Z","timestamp":1455280333000},"page":"673-679","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of ertapenem therapeutic efficacy in the treatment of urinary tract infections (UTIs) in hospitalized adults: the importance of renal insufficiency and urinary pH"],"prefix":"10.1007","volume":"35","author":[{"given":"B. A.","family":"Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Giuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"2586_CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1358\/dot.2002.38.3.820127","volume":"38","author":"BA Cunha","year":"2002","unstructured":"Cunha BA (2002) Ertapenem a, review of its microbiologic, pharmacokinetic and clinical aspects. Drugs of Today (Barc) 38:195\u2013213","journal-title":"Drugs of Today (Barc)"},{"key":"2586_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1358\/dot.2002.38.3.820127","volume":"38","author":"BA Cunha","year":"2002","unstructured":"Cunha BA (2002) Ertapenem. a review of its microbiologic, pharmacokinetic and clinical aspects. Drugs Today 38:195\u2013213","journal-title":"Drugs Today"},{"key":"2586_CR3","doi-asserted-by":"crossref","unstructured":"Grayson ML. Kucers\u2019 The Use of Antibiotics (6th Ed.). Hodder\/Arnold, London, 2010; pp 526\u2013541.","DOI":"10.1201\/b13787"},{"key":"2586_CR4","first-page":"1090","volume":"53","author":"A Alhambra","year":"2004","unstructured":"Alhambra A, Cuadros JA, Cacho J, Gomez-Garces JL, Alos JI (2004) In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. J of Anti Chemo 53:1090\u20131094","journal-title":"J of Anti Chemo"},{"key":"2586_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365548.2011.553241","volume":"43","author":"N Dalgic","year":"2011","unstructured":"Dalgic N, Sancar M, Bayraktar B, Dincer E, Pelit S (2011) Ertapenem for the treatment of urinary tract infections caused by extended spectrum \u00df-lactamase producing bacteria in children. Scand J Infect Dis 43:339\u2013343","journal-title":"Scand J Infect Dis"},{"key":"2586_CR6","first-page":"28","volume":"60","author":"M Trivedi","year":"2012","unstructured":"Trivedi M, Patel V, Soman R, Rodriguez C, Singhal T (2012) The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials. J Asoc Physicians India 60:28\u201330","journal-title":"J Asoc Physicians India"},{"key":"2586_CR7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4111\/kju.2014.55.4.270","volume":"55","author":"S Song","year":"2014","unstructured":"Song S, Kim C, Lim D (2014) Clinical efficacy of ertapenem for recurrent cystitis caused by multidrug resistant extended spectrum \u00df-lactamase-Producing Escherichia coli in female outpatients. Korean J Urol 55:270\u2013275","journal-title":"Korean J Urol"},{"key":"2586_CR8","doi-asserted-by":"crossref","unstructured":"Saltoglu N, Karali R, Yemisen M, Ozaras R, Balkan IIm Mete Bm et al. Comparison of community onset healthcare associated and hospital acquired urinary infections caused by extended spectrum beta lactamase producing Escherichia coli and antimicrobial activities. Int J Clin Pract 2015:69(7):766\u2013770","DOI":"10.1111\/ijcp.12608"},{"key":"2586_CR9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.medmal.2012.07.005","volume":"42","author":"E Forestier","year":"2012","unstructured":"Forestier E, Gros S, Peynaud D, Levast M, Boisseau D, Ferry-Blanco C et al (2012) Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriaceae. Med Mal Infect 42:440\u2013443","journal-title":"Med Mal Infect"},{"key":"2586_CR10","unstructured":"Cunha BA. Antibiotic Essentials (14th Ed.) JayPee Medical Publishers, New Delhi, 2015, pp:2\u201314, 103\u2013105, 608\u2013609."},{"key":"2586_CR11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.urology.2014.03.011","volume":"84","author":"L Yang","year":"2014","unstructured":"Yang L, Wang K, Li H, Denstedt JD, Cadieux PA (2014) The influence of urinary pH on antibiotic efficacy against bacterial uropathogens. Urology 84:e1\u2013e7","journal-title":"Urology"},{"key":"2586_CR12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1139\/W07-097","volume":"53","author":"S Begic","year":"2007","unstructured":"Begic S, Worobec EA (2007) Fluoroquinolone resistance of Serratia marcescens: sucrose, salicylate, temperature, and pH induction of phenotypic resistance. Can J Microbiol 53:1239","journal-title":"Can J Microbiol"},{"key":"2586_CR13","doi-asserted-by":"crossref","unstructured":"So W, Crandon JL, Nicolau DP. Effects of urine matrix and pH on the potency of delafloxacin and ciprofloxacin against urogenic E. coli and K. pneumoniae. J of Urology 2015: ahead of print.","DOI":"10.1016\/j.juro.2015.01.094"},{"key":"2586_CR14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000342423","volume":"90","author":"A Burian","year":"2012","unstructured":"Burian A, Erdogan Z, Jandrsits C, Zeitlinger M (2012) Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine. Pharmacology 90:281\u2013287","journal-title":"Pharmacology"},{"key":"2586_CR15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/phar.1197","volume":"33","author":"DE Wiskirchen","year":"2013","unstructured":"Wiskirchen DE, Housman ST, Quintiliani R et al (2013) Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram\/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers. Pharmacotherapy 33:266\u2013274","journal-title":"Pharmacotherapy"},{"key":"2586_CR16","first-page":"2517","volume":"69","author":"J Zhhou","year":"2014","unstructured":"Zhhou J, Sulaiman Z, Llorin RM, Hee K, Lee S, Lye D et al (2014) Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections. J Anti Chemo 69:2517\u20132521","journal-title":"J Anti Chemo"},{"key":"2586_CR17","doi-asserted-by":"crossref","unstructured":"Lin HA, Yang YS, Wang JX, Lin HC, Lin Y, Chiu CH, et al. Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. J Microbiol Immunol Infect 2015; ahead of print.","DOI":"10.1016\/j.jmii.2014.12.010"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2586-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2586-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2586-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T01:13:00Z","timestamp":1654305180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2586-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2586"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2586-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}